Tech Group Europe Limited t/a West
1 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (1)
- Inspections (2)
Devices registered here (1)
- Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-InitiatedProduct code PZE (opens in a new tab) · Class III · Unknown
Recalls & enforcement
- Class IIOngoing2024-09-24Due to packaging damage from heat exposure during shipping/transportation that may result in a breach in the sterile barrier.
FDA inspections (2)
- VAI2023-04-27Voluntary Action Indicated · Compliance: Devices; Postmarket Assurance: Devices · citations posted
- NAI2019-10-23No Action Indicated · Compliance: Devices
Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.
Related
- All facilities operated by WEST PHARMACEUTICAL SERVICES, INC.
- TECH GROUP GRAND RAPIDS, INC. (MI)
- West Pharma. Services IL, Ltd. (IL)
- West Pharmaceutical Services AZ, Inc. (AZ)
- West Pharmaceutical Services AZ, Inc. (AZ)
- West Pharmaceutical Services AZ, Inc. (AZ)
- West Contract Manufacturing, LLC (PR)
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Tech Group Europe Limited t/a West (FEI 3010893867) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3010893867-tech-group-europe-limited-t-a-west/
Alerts for Tech Group Europe Limited t/a West
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.